Novartis AG
METHODS OF TREATING METABOLIC DISORDERS WITH FGF21 VARIANTS

Last updated:

Abstract:

Provided herein are methods of treating, preventing, and managing metabolic or cardiovascular disorders and methods of reducing cardiovascular risk with FGF21 protein variants, including Fc-FGF21 variant fusion proteins.

Status:
Application
Type:

Utility

Filling date:

21 Dec 2018

Issue date:

3 Dec 2020